Bio-Rad Laboratories Inc
Open
SectorHealthcare
368.69 0.41
Overview
Share price change
24h
Min
364.82
Max
374.71
Income | -2.3M -13M |
|---|---|
Sales | 59M 651M |
P/E Sector Avg | 46.972 56.597 |
EPS | 2.62 |
Profit margin | -2.043 |
Employees | 7,450 |
EBITDA | 1.2B 542M |
Next Earnings | 28 Oct 2026 |
|---|
Market Cap | 1.4B 10B |
|---|---|
Previous open | 368.28 |
Previous close | 368.69 |
News Sentiment
By Acuity
50%
50%
146 / 339 Healthcare
Bio-Rad Laboratories Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Bio-Rad Laboratories Inc Forecast
Sentiment
By Acuity
146 / 339 Healthcare
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Bio-Rad Laboratories Inc
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.